Simulated fibrous tissue for surgical training

Patent metadata

Field	Value
Publication number	US-10692402-B2
Application number	US-201715587438-A
Country	US
Kind code	B2
Filing date	May 5, 2017
Priority date	May 5, 2017
Publication date	Jun 23, 2020
Grant date	Jun 23, 2020

Abstract

Disclosed herein are simulated fibrous tissue models of anatomical parts for surgical training. The non-dissolvable simulated fibrous tissue model is made of a polyvinyl alcohol (PVA) and fibrous material composite to simulate realistic tissue properties and behaviors. The simulated fibrous tissue model may be a standalone model of an anatomical part or may be used in a complementary anatomical simulation kit to provide a more comprehensive training approach.

First claim

The invention claimed is:

1. A method of creating a simulated fibrous tissue model of an anatomical part, the method comprising:
providing a mold of an anatomical part;
providing a complete PVA-fibrous material composite layer, the complete PVA-fibrous material composite layer comprising a plurality of PVA-fibrous material layers, each PVA-fibrous material layer of the plurality of PVA-fibrous material layers comprising a PVA material and a fibrous material-based composite, the fibrous material-based composite comprising a fiberglass mat having a plurality of weave patterns, and providing the complete PVA-fibrous material composite layer comprising:
providing a polyvinyl alcohol (PVA) solution;
applying a volume of the PVA solution onto the mold;
applying a fibrous material onto the volume of the PVA solution, applying the fibrous material comprises providing the fiberglass mat having the plurality of weave patterns; and
applying another volume of the PVA solution onto the fibrous material sufficient to soak through the fibrous material, thereby forming the complete PVA-fibrous material composite layer;

drying the complete PVA-fibrous material composite to conform and set to the shape of the mold;
releasing the complete PVA-fibrous material composite from the mold; and
subjecting the complete PVA-fibrous material composite to at least one freeze-thaw cycle, thereby forming a cryogel, and thereby forming the simulated fibrous tissue model,
whereby the model is imagable with an imaging technique, and
wherein the imaging technique comprises at least one of ultrasound (US), magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET).

2. The method of claim 1 , wherein the model is usable for at least one of demonstrating, testing, and developing at least one of medical functions, medical devices, and surgical training.

3. The method of claim 1 , wherein providing the complete PVA-fibrous material composite layer is repeatable, whereby at least one additional complete PVA-fibrous material composite layer is disposed over a previous complete PVA-fibrous material composite layer.

4. The method of claim 1 , wherein providing the PVA solution comprises: providing PVA in a concentration range of 7% to 10% and in a molecular weight range of 85,000 g/mol to 124,000 g/mol; providing deionized water; providing an antibacterial agent; dissolving the PVA in the deionized water; and at least one of dissolving and admixing the antibacterial agent in the deionized water.

5. The method of claim 1 , wherein applying the fibrous material further comprises providing at least one of a paper, an elastic mesh, a fibrous material of varying density and weave properties to mimic tissue properties and behaviors.

6. The method of claim 1 ,
wherein applying the fibrous material comprises providing a paper, and
wherein providing the paper comprises providing at least one of printed instructions, drawings of hidden anatomy, and a description of a region of interest.

7. The method of claim 1 , wherein providing the mold of the anatomical part comprises providing the mold configured to form a meningeal layer of a mammalian brain.

8. The method of claim 1 ,
wherein providing the mold of the anatomical part comprises providing the mold configured to form at least one simulated anatomical part corresponding to at least one of: abnormalities, vasculature components, and other anatomical components,
wherein the at least one simulated anatomical part provides at least one of a visual mimic and a biomechanical anatomic mimic, and
wherein the at least one simulated anatomical part is embedded within the model to simulate tissue properties and behaviors.

9. The method of claim 1 , wherein providing the PVA solution further comprises providing and admixing at least one of pigments, opacifiers, and other aesthetic components.

10. The method of claim 1 , wherein providing the complete PVA-fibrous material composite layer further comprises embedding at least one of a blueprint and an instruction between any two PVA-fibrous material layers of the plurality of PVA-fibrous material layers to guide at least one of demonstrating, testing, and developing at least one of medical functions, medical devices, and surgical training.

11. The method of claim 1 , wherein the model is at least one of dehydratable and rehydratable.

12. The method of claim 1 , wherein the model is usable for simulating fibrous tissues in the anatomical part.

13. A simulated fibrous tissue model of an anatomical part, comprising:
a tissue model comprising a complete polyvinyl alcohol (PVA)-fibrous material composite layer molded to mimic an anatomical part,
said complete PVA-fibrous material composite layer comprising a plurality of PVA-fibrous material layers, each PVA-fibrous material layer of the plurality of PVA-fibrous material layers comprising a PVA material and a fibrous material-based composite, the fibrous material-based composite comprising a fiberglass mat having a plurality of weave patterns, and
the tissue model configured to mimic tissue properties and behaviors of said anatomical part for medical applications,
wherein the model is imagable with an imaging technique, and
wherein the imaging technique comprises at least one of ultrasound (US), magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET).

14. The model of claim 13 ,
wherein the model comprises at least one simulated anatomical part corresponding to at least one of: abnormalities, vasculature, and anatomical components,
wherein the at least one simulated anatomical part is configured to provide at least one of a visual mimic and a biomechanical mimic, and
wherein the at least one simulated anatomical part is embedded within the model.

15. The model of claim 13 , wherein the PVA material further comprises at least one of pigments, opacifiers, and other aesthetic components.

16. The model of claim 13 , wherein the complete PVA-fibrous material composite layer further comprises at least one of a blueprint and an instruction embedded between any two PVA-fibrous material layers of the plurality of PVA-fibrous material layers to guide at least one of demonstrating, testing, and developing at least one of medical functions, medical devices, and surgical training.

17. The model of claim 13 , wherein the model is usable for simulating fibrous tissues in the anatomical part.

Assignees

• Tyler Brandon William Russell
• Whitton Gregory Allan
• Kerins Fergal
• Synaptive Medical Barbados Inc

Inventors

• Tyler Brandon William Russell
• Whitton Gregory Allan
• Kerins Fergal

Classifications

• B29C41/12

  Spreading-out the material on a substrate {, e.g. on the surface of a liquid} · CPC title

• G09B23/34

  with removable parts · CPC title

• B29C39/003

  characterised by the choice of material · CPC title

• B29L2031/7546

  Surgical equipment · CPC title

• B29K2105/08

  of continuous length, e.g. cords, rovings, mats, fabrics, strands or yarns · CPC title